|
|
Volumn 26, Issue 10, 2008, Pages 1057-1059
|
|
Ark floats gene therapy's boat, for now
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOVIRUS VECTOR;
ADVEXIN;
ANTINEOPLASTIC AGENT;
AROMATIC LEVO AMINO ACID DECARBOXYLASE;
BETA 2 MICROGLOBULIN;
BLOOD CLOTTING FACTOR 9;
CEREPRO;
GANCICLOVIR;
GENE PRODUCT;
GLYBERA;
HLA B7 ANTIGEN;
IMMUNOGLOBULIN FC FRAGMENT;
INGN 241;
INTERLEUKIN 24;
LIPOPROTEIN LIPASE;
METHOTREXATE;
ORNITHINE CARBAMOYLTRANSFERASE;
PROSAVIN;
RETINAL PIGMENT EPITHELIUM SPECIFIC 65 PROTEIN;
RETROVIRUS VECTOR;
TEMOZOLOMIDE;
TNFERADE;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
TUMOR NECROSIS FACTOR ALPHA RECEPTOR;
UNCLASSIFIED DRUG;
APHASIA;
BRAIN CANCER;
CANCER GENE THERAPY;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DRUG MEGADOSE;
DRUG SAFETY;
FAMILIAL CANCER;
FEVER;
FOOD AND DRUG ADMINISTRATION;
GENE THERAPY;
GLIOBLASTOMA;
GRAFT VERSUS HOST REACTION;
HEAD AND NECK CANCER;
HEMIPARESIS;
HISTOPLASMOSIS;
HUMAN;
HYPERLIPOPROTEINEMIA TYPE 1;
IMMUNE RESPONSE;
LEBER CONGENITAL AMAUROSIS;
LIVER TOXICITY;
MELANOMA;
MULTIPLE ORGAN FAILURE;
NOTE;
PANCREAS CANCER;
PARKINSON DISEASE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
VIRAL GENE DELIVERY SYSTEM;
VIRAL GENE THERAPY;
BRAIN NEOPLASMS;
CLINICAL TRIALS, PHASE III AS TOPIC;
ENGLAND;
GENE THERAPY;
HUMANS;
THYMIDINE KINASE;
|
|
EID: 53649094868
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1008-1057 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|
